This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
HIV Seropositivity
and you are
over 18
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The purpose of this study, conducted in Santiago-Chile, was to: 1. Evaluate the sensitivity and specificity of OraQuick Advance oral rapid test (OQA)when compared to ELISA; 2. Track the number of people in the study who returned for their ELISA test HIV results; and 3. Analyze the perception among participants of the use of OQA compared to ELISA testing for HIV screening.

Provided treatments

  • Device: Rapid testing for HIV

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01733927. The sponsor of the trial is Pontificia Universidad Catolica de Chile and it is looking for 497 volunteers for the current phase.
Official trial title:
An Evaluation of an Oral Rapid Test for HIV